Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLCKaiwen Wang, Xiuning Le, Ferdinandos Skoulidis et al.|Journal of Thoracic Oncology|2023Cited by 26
S1701: A randomized phase II trial of carboplatin-paclitaxel with and without ramucirumab in patients with locally advanced, recurrent, or metastatic thymic carcinoma.Anne S. Tsao, Jhanelle E. Gray, Ming-Hui Hsieh et al.|Journal of Clinical Oncology|2024Cited by 5
S1701, A Randomized Phase 2 Trial of Carboplatin-Paclitaxel With and Without Ramucirumab in Patients With Locally Advanced, Recurrent, or Metastatic Thymic CarcinomaAnne S. Tsao, Karen Kelly, Ming-Hui Hsieh et al.|JTO Clinical and Research Reports|2024Cited by 4